Prazepam

Generalized Anxiety Disorder, Anxiety, Anxiety Disorders + 3 more
Treatment
20 Active Studies for Prazepam

What is Prazepam

PrazepamThe Generic name of this drug
Treatment SummaryPrazepam is a type of medication in the benzodiazepine class used to treat anxiety disorders. It is classified as a Schedule IV drug in the United States.
image of different drug pills on a surface
Prazepam Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Prazepam
0

Effectiveness

How Prazepam Affects PatientsPrazepam is a type of drug that is used to reduce anxiety, treat seizures, and help with muscle relaxation. It belongs to a group of drugs called benzodiazepines, which can be addictive if taken for too long or at high doses.
How Prazepam works in the bodyPrazepam works by sending signals to the brain to block arousal in areas responsible for cortical and limbic activity. It does this by stimulating receptors that respond to GABA, a neurotransmitter with an inhibitory effect.

When to interrupt dosage

The measure of Prazepam is contingent upon the diagnosed condition, for example Anxiety Disorders, Generalized Anxiety Disorder and Mental disorders. The amount of dosage is reliant upon the approach of delivery featured in the table below.
Condition
Dosage
Administration
Muscle Relaxation
Generalized Anxiety Disorder
Anxiety
Anxiety Disorders
Mental disorders
Therapeutic procedure

Warnings

Prazepam has six contraindications, thus it should not be taken when experiencing any of the situations listed in the table below.Prazepam Contraindications
Condition
Risk Level
Notes
Liver Failure
Do Not Combine
Pregnancy Trimester, First
Do Not Combine
Obstructive Sleep Apnea (OSA)
Do Not Combine
Myasthenia Gravis
Do Not Combine
Respiratory Insufficiency
Do Not Combine
Severe Hypersensitivity Reactions
Do Not Combine
Prazepam may interact with Pulse Frequency
There are 20 known major drug interactions with Prazepam.
Common Prazepam Drug Interactions
Drug Name
Risk Level
Description
Azelastine
Major
Prazepam may increase the central nervous system depressant (CNS depressant) activities of Azelastine.
Ethanol
Major
Prazepam may increase the central nervous system depressant (CNS depressant) activities of Ethanol.
Methadone
Major
Prazepam may increase the central nervous system depressant (CNS depressant) activities of Methadone.
Oliceridine
Major
The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Prazepam is combined with Oliceridine.
Sodium oxybate
Major
Prazepam may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.
Prazepam Toxicity & Overdose RiskOverdosing on Diclofenac can cause sleepiness, confusion, and loss of consciousness. It is important to monitor the patient's breathing rate, heart rate, and blood pressure.
image of a doctor in a lab doing drug, clinical research

Prazepam Novel Uses: Which Conditions Have a Clinical Trial Featuring Prazepam?

396 active studies are in progress to examine the potential of Prazepam in alleviating Anxiety Disorders, Generalized Anxiety Disorder and Mental afflictions.
Condition
Clinical Trials
Trial Phases
Generalized Anxiety Disorder
185 Actively Recruiting
Not Applicable, Phase 2, Early Phase 1, Phase 4, Phase 3, Phase 1
Therapeutic procedure
0 Actively Recruiting
Muscle Relaxation
0 Actively Recruiting
Mental disorders
9 Actively Recruiting
Phase 2, Phase 1, Early Phase 1, Phase 4, Not Applicable
Anxiety
0 Actively Recruiting
Anxiety Disorders
56 Actively Recruiting
Phase 2, Not Applicable, Phase 4, Phase 3, Early Phase 1

Prazepam Reviews: What are patients saying about Prazepam?

5Patient Review
1/15/2019
Prazepam for Chronic Trouble Sleeping
I was first prescribed this medication in 2011 after my colon cancer diagnosis and subsequent chemotherapy. At that time, my anxiety levels were very high and I couldn't sleep at night. This medication worked wonders for me; just 1.5mg before bed under the tongue did the trick. It's now 2019 and my doctors have taken me off of the medication, saying it's not good for my bones or brain. I haven't been able to sleep properly since going off of it, and they refuse to put me back on it. So I guess I'm screwed.
5Patient Review
4/5/2022
Prazepam for Chronic Trouble Sleeping
Lorazepam is the only medication that works for me. I tried Ambien, Trazadone, and Doxepin before, but they didn't work and had terrible side effects. Lorazepam helps me throughout the day and allows me to sleep for seven to eight hours at night with no nightmares. Without it, I can only sleep for a few hours.
5Patient Review
1/15/2019
Prazepam for Chronic Trouble Sleeping
I was first prescribed this medication in 2011 after my colon cancer diagnosis and chemotherapy. At that time, my anxiety levels were very high and I couldn't sleep at night. This medication worked wonders for me; just 1.5mg before bed under the tongue allowed me to finally get some rest. Fast forward to 2019, my doctors have now taken me off the medication because they say it's not good for my bones or brain, but it's been over a month since I stopped taking it and I still can't sleep properly. They refuse to prescribe it to me again, so I guess I'm screwed.
5Patient Review
4/5/2022
Prazepam for Chronic Trouble Sleeping
Lorazepam is really the only medication that works for me. I tried Ambien, Trazadone, and Doxepin before, but they didn't work and had awful side effects. Lorazepam helps me feel calm throughout the day and I can sleep easily for 7-8 hours at night. There are no negative side effects that I've experienced, just a sense of calmness if you have anxiety.
5Patient Review
1/15/2019
Prazepam for Chronic Trouble Sleeping
I was first prescribed this medication in 2011 after I had to go through colon cancer and chemo. At that time, my anxiety levels were really high and I couldn't sleep at night. This medication worked very well for me; however, now it is 2019 and my doctors have taken me off of it saying it's not good for my bones or brain. It's been over a month since I've taken it and I still don't sleep right. They won't put me back on it so I guess I'm screwed.
5Patient Review
4/5/2022
Prazepam for Chronic Trouble Sleeping
Lorazepam is the only medication that has worked for me. I've tried Ambien, Trazadone, and Doxepin in the past, but they not only didn't work but also had terrible side effects. Lorazepam allows me to have a calm day and an easy 7-8 hour sleep at night without any nightmares. Without it, I can only sleep for a few hours.
5Patient Review
7/18/2022
Prazepam for Mania associated with Bipolar Disorder, Adjunct Treatment
This treatment has been a life-saver for me when it comes to my anxiety and panic attacks.
5Patient Review
8/21/2020
Prazepam for Anxious
This medicine has been a game-changer for me and my anxiety.
5Patient Review
8/21/2020
Prazepam for Anxious
This medicine has been a life saver for me and my anxiety.
5Patient Review
7/18/2022
Prazepam for Mania associated with Bipolar Disorder, Adjunct Treatment
Helps me a lot with my anxiety and panic attacks.
5Patient Review
8/21/2020
Prazepam for Anxious
This medicine has been a godsend for me and my anxiety. It's helped me immensely and I'm extremely grateful for it.
5Patient Review
7/18/2022
Prazepam for Mania associated with Bipolar Disorder, Adjunct Treatment
This drug has really helped me to manage my anxiety and panic attacks.
4.3Patient Review
10/8/2019
Prazepam for Anxious
This drug is effective during the day, but if I take it too close to bedtime I have bad dreams.
4.3Patient Review
5/12/2019
Prazepam for Anxious
The effectiveness of this drug is largely dependent on the user. If you are taking multiple drugs for the same problem, it will be more difficult to gauge the effectiveness of this treatment. However, if you are not mixing it with other medications, it works much better.
4.3Patient Review
5/12/2019
Prazepam for Anxious
The drug's effectiveness is impacted by the user; if you're taking multiple drugs for the same condition, it'll be difficult to gauge how well this one works. That being said, on its own it's much more effective.
4.3Patient Review
5/12/2019
Prazepam for Anxious
The effectiveness of this drug depends on the user. If you are taking multiple drugs for the same problem, it will be harder to tell how effective this drug is. However, if you are not mixing it with other drugs, it works much better.
4.3Patient Review
10/8/2019
Prazepam for Anxious
It's effective during the day, but if I take it too close to bedtime I have bad dreams.
4.3Patient Review
10/8/2019
Prazepam for Anxious
This treatment is effective during the day but gives me bad dreams if I take it too close to bedtime.
4Patient Review
6/5/2022
Prazepam for Anxious
In 2007, I had a stroke. Since then, I've been dealing with anxiety. My doctor put me on an anxiety medication for long-term use, and it has really helped. I only take it as needed, and it's been working great for the past 15 years.
4Patient Review
6/5/2022
Prazepam for Anxious
In 2007, I had a stroke that left me with anxiety. They prescribed me an antianxiety medication to take long term, plus lorazepam as needed. It's been working great for the past 15 years.
4Patient Review
6/5/2022
Prazepam for Anxious
In 2007, I had a stroke at 44 years old. It left me with terrible anxiety. So they gave me an antianxiety medication for long term plus lorazepam. It works wonders and I have been on it for 15 years. Just taken as needed.
3.3Patient Review
4/7/2019
Prazepam for Chronic Trouble Sleeping
I've been taking Lorazepam for three nights now because I have trouble sleeping. However, since starting this medication, I have felt really depressed and miserable. I haven't been able to stop crying. Is this a normal side effect of the medication? Will it go away?
3.3Patient Review
4/7/2019
Prazepam for Chronic Trouble Sleeping
I've only been taking Lorazepam for a short while now, but I am not enjoying the side effects. I'm feeling really down and out, and it's hard to motivate myself to do anything. Hoping this is just a phase that will pass.
3.3Patient Review
4/7/2019
Prazepam for Chronic Trouble Sleeping
I've only been taking Lorazepam for a short while to help me sleep, but I'm suddenly feeling really depressed and miserable. I don't know if this is a normal side effect, but it's really affecting my quality of life. Hoping it goes away soon.
2.7Patient Review
5/18/2022
Prazepam for Anxious
The new Teva brand does not work. I've been using Actavis Watson for years, and they were great. Now that Teva has taken over production, the quality of the tablets has gone downhill significantly.
2.7Patient Review
5/18/2022
Prazepam for Anxious
The new Teva brand does not work. When compared to other generics on the market, this one falls short. Actavis Watson was good.
2.7Patient Review
5/18/2022
Prazepam for Anxious
The new Teva brand does not work. I've been taking these for years, and the switch to in-house production has resulted in a drop in quality. The other generics on the market seem to be bad as well.
2.3Patient Review
4/19/2022
Prazepam for Chronic Trouble Sleeping
I was prescribed 0.5mg before bed, but I didn't feel any effects whatsoever. I'm currently trying 2mg, and while it hasn't helped me sleep yet, I am feeling more relaxed. I'll update this review if anything changes.
2.3Patient Review
4/19/2022
Prazepam for Chronic Trouble Sleeping
I was prescribed 0.5mg before bed. I didn’t feel anything and it hasn’t helped me asleep at all. currently i’m trying 2mg. so far haven't been able to sleep still but am definitely feeling more relaxed. will update
2.3Patient Review
6/27/2022
Prazepam for Delirium
I was in a really bad place mentally and this medication just made it worse.
2.3Patient Review
6/27/2022
Prazepam for Delirium
I was in a bad state of mind and this medication only made it worse.
2.3Patient Review
4/19/2022
Prazepam for Chronic Trouble Sleeping
I was prescribed 0.5mg of this medication to take before bed, but it didn't make me feel any differently and I still couldn't fall asleep. I'm currently taking 2mg per night and while I still haven't been able to sleep, I am feeling more relaxed overall.
2.3Patient Review
6/27/2022
Prazepam for Delirium
I was in a terrible state of mind and constantly panicking, which only made it worse.
1.3Patient Review
1/9/2021
Prazepam for Anxious
I saw no benefits from this treatment.
1.3Patient Review
1/9/2021
Prazepam for Anxious
This didn't do anything for me, unfortunately. Not sure what to do next.
1.3Patient Review
1/9/2021
Prazepam for Anxious
I didn't experience any benefits from this treatment.
1Patient Review
4/18/2019
Prazepam for Anxious
CVS switched to this brand, and I found it to be totally bunk. All the reviews were right—it's ineffective and doesn't work. The company needs to be shut down for fraudulently selling these pills.
1Patient Review
2/6/2019
Prazepam for Anxious
I had an immediate negative reaction to this medication, which included numbness in my lips and brain freeze. I didn't have any issues with the Actives Phara., so it's clear that there's a problem with Leading Pharma's version specifically.
1Patient Review
2/6/2019
Prazepam for Anxious
The moment I took this, my lips went numb and it felt like my brain was frozen. The active ingredient in this pharmaceutical really needs to be better regulated.
1Patient Review
4/18/2019
Prazepam for Anxious
Unfortunately, CVS switched to this brand and I found it did not work at all. It was a total waste of money and time.
1Patient Review
2/6/2019
Prazepam for Anxious
The Leading Pharma version of this medication caused an immediate and bad reaction in me. My lips went numb and my brain felt like it was freeze-drying. I had no problem with the Actives Phara., so I think there's a quality issue that needs to be addressed.
1Patient Review
4/18/2019
Prazepam for Anxious
I was very disappointed with this treatment. It was ineffective and didn't work at all, just like all the other reviews said. I think this company is committing fraud by selling these useless pills.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about prazepam

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is prazepam available in the US?

"The therapeutic effects of prazepam are due to N-desmethyl-diazepam, which is its prodrug. Prazepam is no longer available in the United States."

Answered by AI

What are the side effects of prazepam?

"Gastrointestinal : To large a dose may cause nausea and vomiting.

What are the most common side effects of Prazepam?

The most common side effects of Prazepam are clumsiness or sleepiness. Other side effects include drowsiness, dizziness, weakness, muscle incoordination, fatigue, confusion, faintness, talkativeness, restlessness, anxiety, excitement, trembling, muscle spasms, sleeping problems and nightmares."

Answered by AI

Is prazepam the same as diazepam?

"Prazepam shares the same pharmacological properties as diazepam, with the exception of a longer lasting effect. It is indicated for the same purposes as diazepam. The most common synonym for prazepam is centrax."

Answered by AI

Clinical Trials for Prazepam

Image of University of Rochester Medical Center in Rochester, United States.

Deaf CBT-TS for Suicide Risk

18+
All Sexes
Rochester, NY
The goal of this clinical trial is to learn if a short, Zoom-based intervention, Cognitive Behavioral Therapy for Treatment-Seeking for Deaf Individuals (Deaf CBT-TS) can change beliefs about mental health treatment and increase treatment-seeking behaviors in Deaf adults with untreated mental health or alcohol use problems. It will also see if Deaf CBT-TS may reduce suicide risk and explore factors that may increase the effectiveness of Deaf CBT-TS. The main questions it aims to answer are: * Does Deaf CBT-TS increase positive beliefs about treatment and increase treatment-seeking behaviors? * Does Deaf CBT-TS increase hope and reduce mental health symptoms, suicide ideation, and alcohol use? * Is Deaf CBT-TS more effective for individuals with less cultural stress compared to those with high levels of cultural stress? * Is Deaf CBT-TS more effective for Deaf individuals in residential areas with more Deaf resources than those with less Deaf resources? Researchers will compare individuals who complete Deaf CBT-TS to those on a waitlist to see if Deaf CBT-TS works to increase positive beliefs about treatment and treatment-seeking behaviors. Participants will: * Complete a baseline assessment including demographic information, measures of hope, general mental health and functioning, alcohol use, suicide ideation, cultural stress, and beliefs about treatment. * Receive Deaf CBT-TS (2 sessions) or be placed on a waitlist with the option of receiving Deaf CBT-Ts after 4 months * Complete two follow-up assessments in 2 and 4 months.
Waitlist Available
Has No Placebo
University of Rochester Medical Center
Image of Women's Health Concerns Clinic, St. Joseph's Healthcare Hamilton in Hamilton, Canada.

Mindfulness for Postpartum Anxiety

18+
Female
Hamilton, Canada
Postpartum anxiety (PPA) affects up to 20% of mothers in the first year after delivery, with mothers often reporting both psychological and physical symptoms. Present non-pharmacological interventions are effective at improving some psychological aspects of PPA such as anxiety, depressive mood, and distress. However, current interventions are not effective in improving emotion regulation (ER), something that many with PPA experience impairment in. Current interventions also seldom target the physical aspects of anxiety, such as bodily awareness - sensing and understanding internal signals in the body (e.g., sensing a fast heartbeat). There is a link between ER and bodily awareness, however psychological interventions that target both these aspects have not been investigated in the PPA population. As a result, a mind-body intervention targeting both ER and bodily awareness is needed to offer a more holistic treatment option. The purpose of the proposed study is to test the effectiveness of a 4-week mindfulness intervention on anxiety symptoms, ER, and bodily awareness in those with PPA. We will use self-report questionnaires alongside brain imaging (functional magnetic resonance imaging; fMRI) to evaluate the effectiveness. Combining both subjective and objective measures will provide greater confidence in our findings, ensuring a more comprehensive understanding of the intervention's impact. Self-report questionnaires will be administered at enrolment, immediately post-intervention, and 4 weeks post-intervention. Brain imaging will be conducted at enrolment and immediately post-intervention. We believe this intervention will lead to improvements in anxiety symptoms, ER, and bodily awareness on the questionnaires and fMRI scans. If effective, the proposed mindfulness intervention will target a broader range of psychological and physical symptoms, and reduce the negative impact of PPA on mothers and their infants in Canada and beyond.
Recruiting
Has No Placebo
Women's Health Concerns Clinic, St. Joseph's Healthcare Hamilton (+1 Sites)Sheryl M Green, Ph.D., C.Psych
Image of Cedars-Sinai Medical Center in Los Angeles, United States.

Living Well Program for Anxiety in Breast Cancer

18+
Female
Los Angeles, CA
The goal of this study is to evaluate the efficacy and cost-effectiveness of the Living Well Program, a digital therapeutic application with telecoaching support, in breast cancer patients with moderate-to-severe anxiety. The main question the study aims to answer is: does digital cognitive-behavioral therapy-based interventions decrease the overall healthcare costs of patients with stage II to IV breast cancer? The study has one group of participants who will use the Living Well app and telecoaching support. This group will be compared to retroactively matched controls. Over 3 months, patients will complete 21 mental health modules and 5 telecoaching sessions. In the following 3 months, they will complete any outstanding telecoaching sessions and modules while still being monitored, even if they finished all modules and sessions in the first 3 months. The 6 months after that will be the follow-up phase. They will still have access to the Living Well app and may continue to use it, and they will complete the same assessment questionnaires as baseline to identify any changes in their overall mental health.
Waitlist Available
Has No Placebo
Cedars-Sinai Medical CenterScott Irwin, MD
Have you considered Prazepam clinical trials? We made a collection of clinical trials featuring Prazepam, we think they might fit your search criteria.Go to Trials
Image of Mayo Clinic in Florida in Jacksonville, United States.

Virtual Reality for Cancer

18 - 90
All Sexes
Jacksonville, FL
This clinical trial tests the safety, tolerability, and effectiveness of a virtual reality intervention to improve psychological symptom burden for cancer patients undergoing treatment. Virtual reality (VR) is a technology that allows users to experience and interact with three-dimensional, computer-generated environments that simulate the real world or imagined settings. The VR intervention consists of a preloaded with immersive environments designed to engage the senses through simulated sights and sounds. This may include a walk through of a serene forest, exploring vibrant coral reefs, swimming with dolphins, or standing at the base of a majestic waterfall. These environments are created to provide a relaxing and engaging experience. Completing the VR intervention may be a safe and effective way to improve quality of life, reduce anxiety, enhance focus, and promote healthy living for cancer patients undergoing treatment.
Recruiting
Has No Placebo
Mayo Clinic in FloridaJuan C. Cardenas Rosales, MD
Image of Virtual/ No Physical Facility in Palm City, United States.

Akashic Records Sessions for Mental Health

18+
All Sexes
Palm City, FL
The goal of this clinical study is to learn the impact of two Akashic Records sessions on mental health symptoms in adults. We want to see how sessions are linked to stress, anxiety, and depression, and to resilience (ability to bounce back) and feelings of connectedness (to self, community, and humanity). Main questions this study will answer are: After two sessions, what is the impact on stress, anxiety, and depression? After two sessions, what is the impact on resilience and connectedness? How do participants describe their experience of the sessions? After two sessions, what are participants' views of their problems (insight), emotional experiences (impact) and observable behaviors in their daily life? What participants will do: Complete online surveys about their mood at four points: before the first session, before the second session, after the second session, and again 2 months later. Surveys include: DASS-21 (Depression, Anxiety, and Stress Scale) CD-RISC-10 (Connor-Davidson Resilience Scale) WATTS (Connectedness Scale) A short demographic form and satisfaction survey Attend two individual Akashic Records sessions (50-90 minutes each) over private video platform with a licensed clinical social worker (principal investigator) The first 50 participants will also join a one-hour interview with open ended questions with a licensed clinical social worker (co-investigator) about one week after the second session to share their experience in their own words. Who can take part: Adults ages 18 and older who can read and consent in English and who have experienced stress, anxiety, or low mood in the past year. How the research will happen: Sessions are held by secure video call. Participants will also complete private online surveys before, during, and after the sessions. Some participants may be invited to share their experiences in a one-on-one interview. All information is kept private and names are removed before analysis. Risks and benefits: Talking about personal topics may bring up strong emotions. Licensed clinicians conduct sessions, offer support, and provide referrals if needed. Possible benefits include new insights, greater peace or meaning, and improved coping; benefits are not guaranteed. Why this matters: Many people seek spiritual or transpersonal support for emotional concerns. This pilot study will provide early evidence on whether Akashic Records sessions may be a helpful, low-risk option and will guide future research.
Waitlist Available
Has No Placebo
Virtual/ No Physical FacilityCandice S Rasa, LCSW
Have you considered Prazepam clinical trials? We made a collection of clinical trials featuring Prazepam, we think they might fit your search criteria.Go to Trials
Image of Cresap Laboratory in Evanston, United States.

Dream Yoga Inspired Intervention for Anxiety

18+
All Sexes
Evanston, IL
This is a feasibility study to test whether it is possible to deliver a program inspired by Tibetan Dream Yoga in a modern, accessible way. Dream Yoga is a set of contemplative practices that combine mental exercises during the day with techniques for becoming aware of dreaming within a dream (lucid dreaming) and engage in certain dream activities. The purpose of these practices is to help people explore and loosen rigid patterns of thought and behavior. In this study, the investigators are developing and testing a program that includes guided imagination, meditation, and lucid-dreaming practices, supported by virtual-reality experiences and home-based sleep-monitoring technology. Participants are randomly assigned to either the Dream-Yoga-inspired program or a comparison program focused on general health and sleep education. Because this is a feasibility trial, our main goals are to see whether people are willing and able to take part, whether they find the program acceptable, and whether the investigators can deliver it as planned. The investigators will also explore early signals of change in sleep, dreaming, and thinking. The long-term goal of this research is to determine if such interventions could be beneficial for supporting psychological well-being, improving sleep, and enhancing creativity and flexibility of thought.
Phase < 1
Waitlist Available
Cresap Laboratory (+1 Sites)
Image of Center for Technology and Behavioral Health (CTBH), Geisel School of Medicine at Dartmouth College in Lebanon, United States.

Advertising Claims for Anxiety and Depression

18+
All Sexes
Lebanon, NH
In the U.S., legal cannabis is frequently advertised as an effective treatment for mental health problems such as anxiety and depression-particularly online. States that have legalized cannabis have not implemented regulations to address this type of advertising. This project aims to investigate the influence of psychotherapeutic advertising claims (PAC) and mental health warning labels (WL) on online cannabis purchasing behaviors among light-to-moderate cannabis users with symptoms of depression and/or anxiety. The specific aims are to determine whether PAC increases cannabis purchasing intentions and whether a mental health WL can mitigate this effect. A realistic online cannabis shopping experience will be simulated using the digital Platform for Online Evaluation of Marijuana Marketing and Sales (POEMMS). The study will employ a between-subjects experimental design by randomizing 2,000 participants to one of four online stores that vary in PAC and WL content: (1) a control claims (CC)-only store, (2) a PAC store, (3) a WL store, and (4) a PAC + WL store. Participants will browse and select items as if making real purchases. Analyses will examine three primary outcomes to determine the influence of PAC and WL on purchasing behaviors: (1) total milligrams of THC purchased, (2) average potency (%THC) of products, and (3) overall number of products purchased. The long-term objective is to inform evidence-based cannabis policy and regulatory strategies by understanding the impact of cannabis marketing on vulnerable populations. This research is relevant to public health by addressing the potential risks associated with misleading cannabis marketing, which may lead to increased use and exacerbation of mental health symptoms among individuals with depression and anxiety. The project leverages a multidisciplinary team with expertise in addiction, mental health, epidemiology, and digital health technology. The findings have the potential to inform the development of targeted interventions and policies to reduce harms associated with cannabis advertising-ultimately contributing to better health outcomes and more effective regulation.
Waitlist Available
Has No Placebo
Center for Technology and Behavioral Health (CTBH), Geisel School of Medicine at Dartmouth CollegeJennifer Emond, PHD
Image of Ohio State University Comprehensive Cancer Center in Columbus, United States.

Virtual Reality for Mental Health

18+
All Sexes
Columbus, OH
This clinical trial compares virtual reality viewing of an unaltered streetscape versus a digitally manipulated opposite streetscape to assess the psychosocial response in participants. Visible measures of neighborhood factors might be associated with health outcomes and risk factors of those outcomes. Short-term exposure to virtual reality environments representing very high or very low levels of neighborhood physical disorder - presence or absence of garbage/litter, presence or absence of graffiti, presence or absence of an abandoned building, presence or absence of large dumpsters, poor or very well-kept building conditions, poor or very well-kept yard conditions, poor or very well-kept road verge conditions may be a safe and effective way to assess psychosocial response in participants.
Waitlist Available
Has No Placebo
Ohio State University Comprehensive Cancer CenterJesse Plascak, PhD, MPH
Image of Florida International University in Miami, United States.

Biofeedback for Anxiety

18 - 35
All Sexes
Miami, FL
This study aims to evaluate the effectiveness of a four-week heart rate variability (HRV) biofeedback intervention to improve physiological stress response, emotion regulation, and anxiety-related symptoms in young ethnic minority adults with a family history of cardiovascular disease (CVD). Participants will be randomly assigned to either an intervention group, where they will engage in guided paced breathing exercises, or a control group, which will follow standard conditions without the intervention. The study consists of five sessions, including an initial assessment, three weekly check-in sessions, and a final post-intervention assessment. Participants will practice paced breathing at home and attend brief in-lab sessions to track progress. Physiological and psychological measures, such as HRV, GSR, BP, anxiety levels, and responses to the Socially Evaluated Cold Pressor Test (SECPT), will be used to assess outcomes. Findings from this study may provide insights into accessible, non-invasive stress management interventions to mitigate CVD risk in high-risk populations.
Recruiting
Has No Placebo
Florida International UniversityAmelia D Saul, PhD
Have you considered Prazepam clinical trials? We made a collection of clinical trials featuring Prazepam, we think they might fit your search criteria.Go to Trials
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security